PrecisCa
PrecisCa supports patients, their caregivers, and health care providers at every step of their cancer journeys from diagnosis to remission, with up-to-date education on the latest advancements in cancer care and access to leading specialists to analyze patient scenarios
Heme Tumor Board: 65 y/o Female With R/R IgA Kappa MM Undergone Numerous Lines of Treatment Presented With Symptomatic, Progressive Disease With New Bony Lytic Lesions and Extramedullary Disease Involvement
Login to view comments.
Click here to Login
